New experimental models of skin homeostasis and diseases;Nuevos modelos experimentales para el estudio de la homeostasis y la enfermedad cutánea

Actas Dermo-Sifiliograficas

Volumn 106, Issue 1, 2015, Pages 17-28

  Larcher, F ^a   Espada, J ^b,c   Diaz Ley B ^d   Jaen P ^d   Juarranz, A ^b   Quintanilla, M ^c  

^a CIEMAT   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Epidermal stem cells; SkinModel CM software

Indexed keywords

DNA METHYLTRANSFERASE 1; ENDOGLIN; PODOPLANIN; DNA (CYTOSINE 5) METHYLTRANSFERASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL CELL NEVUS SYNDROME; CELL ACTIVITY; EPIDERMIS CELL; EXPERIMENTAL MODEL; HOMEOSTASIS; HOMEOSTASIS AND REGULATION; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; SKIN CANCER; SKIN DISEASE; STEM CELL; XERODERMA PIGMENTOSUM; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENETICS; HAIR FOLLICLE; HUMAN; MEDICAL RESEARCH; MOUSE; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; SKIN DISEASES; BIOENGINEERING; BIOLOGICAL ACTIVITY; CLINICAL RESEARCH; EPIDERMAL STEM CELL; GENETIC MODEL; GENETICALLY ENGINEERED MOUSE STRAIN; PROCESS OPTIMIZATION; SHORT SURVEY; SKIN FUNCTION;

ANIMALS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; HAIR FOLLICLE; HOMEOSTASIS; HUMANS; MICE; MODELS, ANIMAL; MODELS, GENETIC; PHOTOCHEMOTHERAPY; SKIN DISEASES; SKIN PHYSIOLOGICAL PHENOMENA; STEM CELLS;

EID: 84922403676     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2014.11.013     Document Type: Short Survey

References (61)

1. L.C. Tsoi, S.L. Spain, J. Knight, E. Ellinghaus, P.E. Stuart, and F. Capon Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity Nat Genet 44 2012 1341 1348
2. J. Lomas, P. Martin-Duque, M. Pons, and M. Quintanilla The genetics of malignant melanoma Front Biosci 13 2008 5071 5093
3. M. Di Magliano, and M. Hebrok Hedgehog signalling in cancer formation and maintenance Nat Rev Cancer 3 2003 903 911
4. A. Burgeiro, F. Mollinedo, and P.J. Oliveira Ipilimumab and vemurafenib. Two different routes for targeting melanoma Curr Cancer Drug Targets 13 2013 879 894
5. C.M. Rudin Vismodegib Clin Cancer Res 18 2012 3218 3222
6. C. Blanpain, and E. Fuchs Epidermal homeostasis: A balancing act of stem cells in the skin Nat Rev Mol Cell Biol 10 2009 207 217
7. S.M. Hussein, and A.A. Nagy Progress made in the reprogramming field: New factors, new strategies and a new outlook Curr Opin Genet Dev 22 2012 435 443
8. H. Clevers The cancer stem cells: Premises, promises and challenges Nat Med 17 2011 313 319
9. G. Cotsarelis, T.T. Sun, and R.M. Lavker Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle and skin carcinogenesis Cell 61 1990 1329 1337
10. E.N. Arwert, E. Hoste, and F.M. Watt Epithelial stem cells, wound healing and cancer Nat Rev Cancer 12 2012 170 180
11. J. Goldstein, and V. Horsley Home sweet home: Skin stem cells niches Cell Mol Life Sci 69 2012 2573 2582
12. P. Mistriotis, and S.T. Andreadis Hair follicle: A novel source of multipotent stem cells for tissue engineering and regenerative medicine Tissue Eng Part B Rev 19 2013 265 278
13. K.S. Stenn, and R. Paus Controls of hair follicle cycling Physiol Rev 81 2001 449 494
14. L. Yang, and R. Peng Unveiling hair follicle stem cells Stem Cell Rev 6 2010 658 664
15. P. Owens, G. Han, A.G. Li, and X.J. Wang The role of Smads in skin development J Invest Dermatol 128 2008 783 790
16. J. Espada, H. Peinado, L. Lopez-Serra, F. Setién, P. Lopez-Serra, and A. Portela Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context Nucleic Acids Res 39 2011 9194 9205
17. C. Bernabeu, J.M. Lopez-Novoa, and M. Quintanilla The emerging role of the TGF-β coreceptors in cancer Biochim Biophys Acta 1792 2009 954 973
18. S.H. Yuspa The pathogenesis of squamous cell cancer: Lesson learned from studies of skin carcinogenesis-thirty-third G. H. A. Clowes Memorial Award Lecture Cancer Res 54 1994 1178 1189
19. R.J. Akhurst, and A. Balmain Genetic events and the role of TGF-beta in epithelial tumor progression J Pathol 187 1999 82 90
20. E.L. Abel, J.M. Angel, K. Kiguchi, and J. di Giovanni Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications Nat Protoc 4 2009 1350 1362
21. M. Herzig, and G. Christofori Recent advances in cancer research: Mouse models of tumorigenesis Biochim Biophys Acta 1602 2002 97 103
22. D. Quigley, and A. Balmain Systems genetics analysis of cancer susceptibility: From mouse models to humans Nat Rev Genet 10 2009 651 657
23. A. Gandarillas, F.G. Scholl, N. Benito, C. Gamallo, and M. Quintanilla Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis Mol Carcinog 20 1997 10 18
24. F.G. Scholl, C. Gamallo, and M. Quintanilla Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression Lab Invest 80 2000 1749 1759
25. E. Martín-Villar, D. Megías, S. Castel, M.M. Yurrita, S. Vilaró, and M. Quintanilla Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition J Cell Sci 119 2006 4541 4553
26. M. Quintanilla, J.R. Ramirez, E. Pérez-Gómez, D. Romero, B. Velasco, and M. Letarte Expression of the TGF-β coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis Oncogene 22 2003 5976 5985
27. W. Cui, D.J. Fowlis, S. Bryson, E. Duffie, H. Ireland, and A. Balmain TGFbeta1 inhibits the formation of benign skin tumors, but enhance progression to invasive spindle carcinomas in transgenic mice Cell 86 1996 531 542
28. A.B. Roberts, and L.M. Wakefield The two faces of transforming growth factor beta in carcinogenesis Proc Natl Acad Sci U S A 100 2003 8621 8623
29. E. Pérez-Gómez, M. Villa-Morales, J. Santos, J. Fernández-Piqueras, C. Gamallo, and J. Dotor A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis. A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis Cancer Res 67 2007 10268 10277
30. R.D. Palmiter, and R.L. Brinster Germ-line transformation of mice Annu Rev Genet 20 1986 465 499
31. M.R. Capecchi The new mouse genetics: Altering the genome by gene targeting Trends Genet 5 1989 70 76
32. A. Ramírez, M. Vidal, A. Bravo, F. Larcher, and J.L. Jorcano A 5′-upstream region of a bovine keratin 6 gene confers tissue-specific expression and hyperproliferation-related induction in transgenic mice Proc Natl Acad Sci U S A 92 1995 4783 4787
33. F. Larcher, R. Murillas, M. Bolontrade, C.J. Conti, and J.L. Jorcano VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development Oncogene 17 1998 303 311
34. M.R. Schneider Genetic mouse models for skin research: Strategies and resources Genesis 50 2012 652 664
35. F. Larcher, A. Ramirez, M.L. Casanova, M. Navarro, J. Paramio, and P. Perez Understanding skin carcinogenesis through transgenic approaches Current Genomics 3 2002 335 353
36. A. Nagy Cre recombinase: The universal reagent for genome tailoring Genesis 26 2000 99 109
37. K. Kretzschmar, and F.M. Watt Lineage tracing Cell 148 2012 33 45
38. C.J. Kemp Multistep skin cancer in mice as a model to study the evolution of cancer cells Semin Cancer Biol 15 2005 460 473
39. K.Y. Tsai, and H. Tsao The genetics of skin cancer Am J Med Genet C 131C 2004 82 92
40. A. Meana, J. Iglesias, M. del Río, F. Larcher, B. Madrigal, and M.F. Fresno Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels Burns 24 1998 621 630
41. L. Martínez-Santamaría, S. Guerrero-Aspizua, and M. del Rio Bioingeniería cutánea: aplicaciones preclínicas y clínicas Actas Dermosifiliogr 103 2012 5 11
42. S. Muffler, H.J. Stark, M. Amoros, B. Falkowska-Hansen, K. Boehnke, and H.J. Bühring A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures Stem Cells 26 2008 2506 2515
43. M. Garcia, M.J. Escamez, M. Carretero, I. Mirones, L. Martinez-Santamaria, and M. Navarro Modeling normal and pathological processes through skin tissue engineering Mol Carcinog 46 2007 741 745
44. Y. Gache, C. Baldeschi, M. del Rio, L. Gagnoux-Palacios, F. Larcher, and J.P. Lacour Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa Hum Gene Ther 15 2004 921 933
45. F. Di Nunzio, G. Maruggi, S. Ferrari, E. di Iorio, V. Poletti, and M. Garcia Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors Mol Ther 16 2008 1977 1985
46. M. García, F. Larcher, R.P. Hickerson, E. Baselga, S.A. Leachman, and R.L. Kaspar Development of skin-humanized mouse models of pachyonychia congenita J Invest Dermatol 131 2011 1053 1060
47. W.L. Di, F. Larcher, E. Semenova, G.E. Talbot, J.I. Harper, and M. del Rio Ex vivo gene therapy restores LEKT1 activity and corrects the architecture of Netherton syndrome-derived skin grafts Mol Ther 19 2011 408 416
48. M. García, S. Llames, E. García, A. Meana, N. Cuadrado, and M. Recasens In vivo assessment of acute UVB responses in normal and xeroderma pigmentosum (XP-C) skin-humanized mouse models Am J Pathol 177 2010 865 872
49. K. Aufenvenne, R.H. Rice, I. Hausser, V. Oji, H.C. Hennies, and M.D. Rio Long-term faithful recapitulation of transglutaminase 1-deficient lamellar ichthyosis in a skin-humanized mouse model, and insights from proteomic studies J Invest Dermatol 132 2012 1918 1921
50. S. Guerrero-Aspizua, M. García, R. Murillas, L. Retamosa, N. Illera, and B. Duarte Development of a bioengineered skin-humanized mouse model for psoriasis dissecting epidermal-lymphocyte interacting pathways Am J Pathol 177 2010 3112 3124
51. F. Larcher, E. Dellambra, L. Rico, S. Bondanza, R. Murillas, and C. Cattoglio Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy Mol Ther 15 2007 1670 1676
52. A. Lomas, J. Leonardi-Bee, and F. Bath-Hextall A systematic review of worldwide incidence of nonmelanoma skin cancer Br J Dermatol 166 2012 1069 1080
53. V. Smith, and S. Walton Treatment of facial basal cell carcinoma: A review J Skin Cancer 2011 2011 380371
54. A. Juarranz, P. Jaén, F. Sanz-Rodríguez, J. Cuevas, and S. González Photodynamic therapy of cancer. Basic principles and applications Clin Transl Oncol 10 2008 148 154
55. A. Giménez-Banzo, M.L. Sagristà, M. Mora, and S. Nonell Kinetics of singlet oxygen photosensitization in human skin fibroblasts Free Radic Biol Med 44 2008 1926 1934
56. E. Buytaert, M. Dewaele, and P. Agostinis Molecular effectors of multiple cell death pathways initiated by photodynamic therapy Biochim Biophys Acta 1776 2007 86 107
57. A.R. Soares, M.G. Neves, A.C. Tomé, M.C. Iglesias-de la Cruz, A. Zamarrón, and E. Carrasco Glycophthalocyanines as photosensitizers for triggering mitotic catastrophe and apoptosis in cancer cells Chem Res Toxicol 25 2012 940 951
58. J. Kloek, and G.M. Beijersbergen van Henegouwen Prodrugs of 5-aminolevulinic acid for photodynamic therapy Photochem Photobiol 64 1996 994 1000
59. K. Gardlo, and T. Ruzicka Metvx (PhotoCure) Curr Opin Investig Drugs 3 2002 1672 1678
60. P. Babilas, S. Karrer, A. Sidoroff, M. Landthaler, and R.M. Szeimies Photodynamic therapy in dermatology-an update Photodermatol Photoimmunol Photomed 21 2005 142 149
61. A. Blázquez-Castro, E. Carrasco, M.I. Calvo, P. Jaén, J.C. Stockert, and A. Juarranz Protoporphyrin IX-dependent photodynamic production of endogenous ROS stimulates cell proliferation Eur J Cell Biol 91 2012 216 223